RhumbLine Advisers’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $6.89M | Sell |
|
|||||
|
2025
Q2 | $4.98M | Buy |
|
|||||
|
2025
Q1 | $4.86M | Buy |
|
|||||
|
2024
Q4 | $4.47M | Buy |
|
|||||
|
2024
Q3 | $6.84M | Buy |
|
|||||
|
2024
Q2 | $5.78M | Buy |
|
|||||
|
2024
Q1 | $3.03M | Buy |
|
|||||
|
2023
Q4 | $1.04M | Buy |
|
|||||
|
2023
Q3 | $705K | Sell |
|
|||||
|
2023
Q2 | $1.23M | Buy |
|
|||||
|
2023
Q1 | $1.49M | Buy |
|
|||||
|
2022
Q4 | $1.78M | Buy |
|
|||||
|
2022
Q3 | $1.26M | Buy |
|
|||||
|
2022
Q2 | $1.01M | Buy |
|
|||||
|
2022
Q1 | $852K | Buy |
|
|||||
|
2021
Q4 | $1.05M | Buy |
|
|||||
|
2021
Q3 | $1.05M | Buy |
|
|||||
|
2021
Q2 | $927K | Buy |
|
|||||
|
2021
Q1 | $666K | Buy |
|
|||||
|
2020
Q4 | $493K | Buy |
|
|||||
|
2020
Q3 | $493K | Buy |
|